ENGN insider transaction filings
enGene Therapeutics Inc. — 35 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-17. Screen ENGN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | Joustra Wouter — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Grossman William — Interim Chief Medical Officer, Director | Grant/award (A): 31,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Heffernan Michael Thomas — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | BRUNK GERALD A — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Astley-Sparke Philip — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Glickman Richard M — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | HASTINGS PAUL J — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Zoth Lota S. — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | CHEUNG ANTHONY TZEYEW — Chief Scientific Officer | Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Nichols Alexander Julian — Chief Strategy & Ops. Ofc | Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Connolly Joan — Chief Technology Officer | Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Boyd Matthew Ross — Chief Regulatory Officer | Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Giguere Lee — Chief Legal Ofc. and Corp Secy | Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Buck Jill — Chief Development Officer | Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Cooper Ronald Harold Wilfred — CEO & President, Director | Grant/award (A): 801,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Daws D. Ryan — Chief Financial Officer | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | Sweiti Hussein — Chief Medical Officer | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-07-14 | 4 | Boyd Matthew Ross — Chief Regulatory Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Buck Jill — Chief Development Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Grossman William — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Heffernan Michael Thomas — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Astley-Sparke Philip — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Joustra Wouter — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Bos Jasper — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Pott Amy — Chief Global Comm. Ofc. | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | BRUNK GERALD A — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Glickman Richard M — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | HASTINGS PAUL J — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Zoth Lota S. — Director | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Pruthi Raj Som — Chief Medical Officer | Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Nichols Alexander Julian — Chief Strategy & Ops. Ofc | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | CHEUNG ANTHONY TZEYEW — Chief Scientific Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Giguere Lee — Chief Legal Ofc. and Corp Secy | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Cooper Ronald Harold Wilfred — CEO & President, Director | Grant/award (A): 850,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Daws D. Ryan — Chief Financial Officer | Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — enGene Therapeutics Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K/A | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-15 | 8-K | 2.02 — Results of Operations and Financial Condition ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ENGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →